Clinical trial
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART…
NCT00107887 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00107887 |
|---|---|
| Title | TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) |
| Official title | Impact of TB Preventive Therapy for HIV/TB Co-infected Patients With Access to Highly Active Antiretroviral Therapy in Rio de Janeiro, Brazil: A Phased Implementation Trial |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic Communicable Disease Program, Brazil Bill and Melinda Gates Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tuberculosis, HIV Infections |
| Intervention type | Drug |
| Interventions | INH preventive therapy, TST (tuberculin skin test) |
| Enrollment | 17,415 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Apr 12, 2005 |
| Last update posted | Jun 15, 2011 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: